British Journal of Cancer - Table of Contents alert Volume 113 Issue 2

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 113, Issue 2 (193-363) Published online 14 July 2015 In this issue Minireview Clinical Studies Translational Therapeutics Molecular Diagnostics Genetics & Genomics Also new today Advance online publication Digital Edition Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement lntroducing the Darwin Blog — "keeping an evolutionary eye on cancer." Led by Prof. Mel Greaves and brought to you by the British Journal of Cancer. The blog provides a new forum for those with a Darwinian perspective on new thinking and developments in cancer research - aiming to encourage discussion and debate among specialists and general interest readers. »Start reading the latest content   Minireview Top The genomic evolution of human prostate cancer T Mitchell and D E Neal Br J Cancer 2015 113: 193-198; advance online publication, June 30, 2015; 10.1038/bjc.2015.234 Abstract | Full Text Clinical Studies Top Impact of KRAS codon subtypes from a randomised phase II trial of selumetinib plus docetaxel in KRAS mutant advanced non-small-cell lung cancer P A Jänne, I Smith, G McWalter, H Mann, B Dougherty, J Walker, M C M Orr, D R Hodgson, A T Shaw, J R Pereira, G Jeannin, J Vansteenkiste, C H Barrios, F A Franke, L Crinò and P Smith Br J Cancer 2015 113: 199-203; advance online publication, June 30, 2015; 10.1038/bjc.2015.215 Abstract | Full Text Systemic neutrophil-to-lymphocyte ratio in colorectal cancer: the relationship to patient survival, tumour biology and local lymphocytic response to tumour J K Pine, E Morris, G G Hutchins, N P West, D G Jayne, P Quirke and K R Prasad Br J Cancer 2015 113: 204-211; advance online publication, June 30, 2015; 10.1038/bjc.2015.87 Abstract | Full Text Prognostic value of lymph node ratio and extramural vascular invasion on survival for patients undergoing curative colon cancer resection C N Parnaby, N W Scott, G Ramsay, C MacKay, L Samuel, G I Murray and M A Loudon Br J Cancer 2015 113: 212-219; advance online publication, June 16, 2015; 10.1038/bjc.2015.211 Abstract | Full Text A phase II and pharmacodynamic study of sunitinib in relapsed/refractory oesophageal and gastro-oesophageal cancers C Wu, S Mikhail, L Wei, C Timmers, S Tahiri, A Neal, J Walker, S El-Dika, M Blazer, J Rock, D J Clark, X Yang, J L Chen, J Liu, M V Knopp and T Bekaii-Saab Br J Cancer 2015 113: 220-225; advance online publication, July 7, 2015; 10.1038/bjc.2015.197 Abstract | Full Text Prognostic value and kinetics of circulating endothelial cells in patients with recurrent glioblastoma randomised to bevacizumab plus lomustine, bevacizumab single agent or lomustine single agent. A report from the Dutch Neuro-Oncology Group BELOB trial N Beije, J Kraan, W Taal, B van der Holt, H M Oosterkamp, A M Walenkamp, L Beerepoot, M Hanse, M E van Linde, A Otten, R M Vernhout, F Y F de Vos, J W Gratama, S Sleijfer and M J van den Bent Br J Cancer 2015 113: 226-231; advance online publication, June 4, 2015; 10.1038/bjc.2015.191 Abstract | Full Text Translational Therapeutics Top Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma E T Wong, E Lok, S Gautam and K D Swanson Br J Cancer 2015 113: 232-241; advance online publication, June 30, 2015; 10.1038/bjc.2015.238 Abstract | Full Text Dual inhibition of survivin and MAOA synergistically impairs growth of PTEN-negative prostate cancer S Xu, H Adisetiyo, S Tamura, F Grande, A Garofalo, P Roy-Burman and N Neamati Br J Cancer 2015 113: 242-251; advance online publication, June 23, 2015; 10.1038/bjc.2015.228 Abstract | Full Text Molecular Diagnostics Top miR-9-3p plays a tumour-suppressor role by targeting TAZ (WWTR1) in hepatocellular carcinoma cells T Higashi, H Hayashi, T Ishimoto, H Takeyama, T Kaida, K Arima, K Taki, K Sakamoto, H Kuroki, H Okabe, H Nitta, D Hashimoto, A Chikamoto, T Beppu and H Baba Br J Cancer 2015 113: 252-258; advance online publication, June 30, 2015; 10.1038/bjc.2015.170 Abstract | Full Text Overexpression of connexin 43 reduces melanoma proliferative and metastatic capacity A Tittarelli, I Guerrero, F Tempio, M A Gleisner, I Avalos, S Sabanegh, C Ortíz, L Michea, M N López, A Mendoza-Naranjo and F Salazar-Onfray Br J Cancer 2015 113: 259-267; advance online publication, July 2, 2015; 10.1038/bjc.2015.162 Abstract | Full Text Evaluation of serum CEA, CYFRA21-1 and CA125 for the early detection of colorectal cancer using longitudinal preclinical samples D S Thomas, E-O Fourkala, S Apostolidou, R Gunu, A Ryan, I Jacobs, U Menon, W Alderton, A Gentry-Maharaj and J F Timms Br J Cancer 2015 113: 268-274; advance online publication, June 2, 2015; 10.1038/bjc.2015.202 Abstract | Full Text Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer T Matsumura, K Sugimachi, H Iinuma, Y Takahashi, J Kurashige, G Sawada, M Ueda, R Uchi, H Ueo, Y Takano, Y Shinden, H Eguchi, H Yamamoto, Y Doki, M Mori, T Ochiya and K Mimori Br J Cancer 2015 113: 275-281; advance online publication, June 9, 2015; 10.1038/bjc.2015.201 Abstract | Full Text Tumour-suppressive microRNA-144-5p directly targets CCNE1/2 as potential prognostic markers in bladder cancer R Matsushita, N Seki, T Chiyomaru, S Inoguchi, T Ishihara, Y Goto, R Nishikawa, H Mataki, S Tatarano, T Itesako, M Nakagawa and H Enokida Br J Cancer 2015 113: 282-289; advance online publication, June 9, 2015; 10.1038/bjc.2015.195 Abstract | Full Text miR-30e* is an independent subtype-specific prognostic marker in breast cancer F D'Aiuto, M Callari, M Dugo, G Merlino, V Musella, P Miodini, B Paolini, V Cappelletti and M G Daidone Br J Cancer 2015 113: 290-298; advance online publication, June 9, 2015; 10.1038/bjc.2015.206 Abstract | Full Text A clinically applicable molecular-based classification for endometrial cancers A Talhouk, M K McConechy, S Leung, H H Li-Chang, J S Kwon, N Melnyk, W Yang, J Senz, N Boyd, A N Karnezis, D G Huntsman, C B Gilks and J N McAlpine Br J Cancer 2015 113: 299-310; advance online publication, June 30, 2015; 10.1038/bjc.2015.190 Abstract | Full Text Preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios predict endometrial cancer survival M Cummings, L Merone, C Keeble, L Burland, M Grzelinski, K Sutton, N Begum, A Thacoor, B Green, J Sarveswaran, R Hutson and N M Orsi Br J Cancer 2015 113: 311-320; advance online publication, June 16, 2015; 10.1038/bjc.2015.200 Abstract | Full Text Expression of p16 in squamous cell carcinoma of the mobile tongue is independent of HPV infection despite presence of the HPV-receptor syndecan-1 N Sgaramella, P J Coates, K Strindlund, L Loljung, G Colella, G Laurell, R Rossiello, L L Muzio, C Loizou, G Tartaro, K Olofsson, K Danielsson, R Fåhraeus and K Nylander Br J Cancer 2015 113: 321-326; advance online publication, June 9, 2015; 10.1038/bjc.2015.207 Abstract | Full Text Oncogenic CXCL10 signalling drives metastasis development and poor clinical outcome S C Wightman, A Uppal, S P Pitroda, S Ganai, B Burnette, M Stack, G Oshima, S Khan, X Huang, M C Posner, R R Weichselbaum and N N Khodarev Br J Cancer 2015 113: 327-335; advance online publication, June 4, 2015; 10.1038/bjc.2015.193 Abstract | Full Text The von Hippel–Lindau tumour suppressor gene: uncovering the expression of the pVHL172 isoform F Chesnel, P Hascoet, J P Gagné, A Couturier, F Jouan, G G Poirier, C Le Goff, C Vigneau, Y Danger, F Verite, X Le Goff and Y Arlot-Bonnemains Br J Cancer 2015 113: 336-344; advance online publication, June 2, 2015; 10.1038/bjc.2015.189 Abstract | Full Text The expression of tumour suppressors and proto-oncogenes in tissues susceptible to their hereditary cancers Brian Muir and Leonard Nunney Br J Cancer 2015 113: 345-353; advance online publication, June 16, 2015; 10.1038/bjc.2015.205 Abstract | Full Text Genetics & Genomics Top MC1R gene variants and non-melanoma skin cancer: a pooled-analysis from the M-SKIP project E Tagliabue, M C Fargnoli, S Gandini, P Maisonneuve, F Liu, M Kayser, T Nijsten, J Han, R Kumar, N A Gruis, L Ferrucci, W Branicki, T Dwyer, L Blizzard, P Helsing, P Autier, J C García-Borrón, P A Kanetsky, M T Landi, J Little, J Newton-Bishop, F Sera and S Raimondi for the M-SKIP Study Group Br J Cancer 2015 113: 354-363; advance online publication, June 23, 2015; 10.1038/bjc.2015.231 Abstract | Full Text Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.